|
[Related PubMed/MEDLINE] Total Number of Papers: 6
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2018 |
Activation of PAR4 Upregulates p16 through Inhibition of DNMT1 and HDAC2 Expression via MAPK Signals in Esophageal Squamous Cell Carcinoma Cells. |
ChIP-PCR, DNMT1, ESCC, HDAC2, PAR4 |
2 |
2018 |
Downregulation of iNOS, IL-1beta, and P2X7 Expression in Mast Cells via Activation of PAR4 Contributes to the Inhibition of Visceral Hyperalgesia in Rats. |
BMMCs, IL-1beta, iNOS, MAPK, MCs, P2X7, PAR4 |
3 |
2018 |
Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca2+ mobilization and ERK phosphorylation in healthy Japanese subjects. |
PAR4, PARs |
4 |
2018 |
Quantitative Proteomics Identify the Possible Tumor Suppressive Role of Protease-Activated Receptor-4 in Esophageal Squamous Cell Carcinoma Cells. |
ESCC, PAR4 |
5 |
2018 |
The protease-activated receptor4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor4 desensitization, and is blocked by non-competitive P2Y12 inhibition. |
PAR, SNP |
6 |
2016 |
Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1. |
HMGB1, IC/PBS, MIF, PAR4, UROtsa |
|